CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac Group Ltd.’s Diagnostics Business Unit today announced the validated results of the ALM AADx assay, a gene expression test that identifies a subgroup of high grade serous ovarian cancer (HGSOC) patients that have a good prognosis following standard of care chemotherapy.
Help employers find you! Check out all the jobs and post your resume.
